Comparison of the Effects of External Oblique Intercostal Plane Block and Subcostal Transversus Plane Block Methods With Ultrasound Guidance on Postoperative Analgesia in Laparoscopic Sleeve Gastrectomy Operations

April 20, 2026 updated by: MELİKE BOSTANCI ERKMEN, Sanliurfa Education and Research Hospital
The primary aim of this study was to investigate the effects of the external oblique intercostal plane block and the subcostal transversus abdominis plane block on postoperative pain scores and opioid consumption in patients undergoing laparoscopic sleeve gastrectomy.

Study Overview

Detailed Description

Obesity is a global health problem currently treated with diet, pharmacotherapy, and bariatric surgery. Laparoscopic sleeve gastrectomy (LSG) is a common bariatric procedure that often results in moderate to severe postoperative pain. Adequate pain control after LSG is crucial for early mobilization and prevention of complications . As a relatively novel technique, the external oblique intercostal block (EOIB) provides analgesia for anterolateral upper abdominal surgery by blocking both the lateral and anterior cutaneous branches of the intercostal nerves between T6-7 and T10-11 . The subcostal transversus abdominis plane (s-TAP) block provides sensory blockade over nearly the entire anterior abdominal wall between T6 and T9. Therefore, it can be considered as part of multimodal analgesia for both laparotomy and laparoscopic abdominal surgical procedures.

The primary aim of this study was to investigate the effects of the external oblique intercostal block (EOIB) and the subcostal transversus abdominis plane (s-TAP) block on postoperative pain scores and opioid consumption in patients undergoing laparoscopic sleeve gastrectomy.

Study Type

Interventional

Enrollment (Estimated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Şanlıurfa
      • Sanliurfa, Şanlıurfa, Turkey (Türkiye), 63200
        • Sanliurfa Education and Research Hospital
        • Contact:
          • Sanliurfa Education and Research Hospital bostancı erkmen, MD
          • Phone Number: +9005355708530
          • Email: mlkbstnci@gmail.com
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adult patients aged between 18 and 65 years
  • Patients classified as American Society of Anesthesiologists (ASA) physical status I-III

Exclusion Criteria:

  • Patients younger than 18 years or older than 65 years
  • Inability to cooperate or comply with study procedures
  • Liver and kidney failure
  • American Society of Anesthesiologists (ASA) IV-V patient
  • External oblique intercostal block(EOİB) and the Subcostal Transversus Abdominis Plane block(s-TAB) are contraindicated

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: External Oblique Intercostal Block
patient receive block that External Oblique Intercostal Blcok
Ultrasound-guided external oblique intercostal plane block will be performed at the T6 level using 20 ml of 0.25% bupivacaine at the Immediately after intubation
Experimental: Subcostal Transversus Abdominis Plane Block (s-TAP)
Patient receive that OSTAP
Ultrasound-guided OSTAP block will be performed using 20 ml of 0.25% bupivacaine immediately after intubation.
Experimental: Local anesthetic infiltration
Surgeon implement local anesthetic to port site
Port-site local anesthetic infiltration will be performed with bupivacain after intubation by surgeon.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative Acute Pain Scores
Time Frame: postoperative T1: 0. hours, T2:4.hours,T3:12.hours,T4: 24.hours
Postoperative acute pain scores assingment with Visual Analog Scores
postoperative T1: 0. hours, T2:4.hours,T3:12.hours,T4: 24.hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total Opioid Consumption
Time Frame: POSTOPERATİVE T1:0 HOURS T2:4. HOURS T3:12.HOURS T4:24.HOURS
We plan to investigate the effects of the external oblique intercostal block and the subcostal transversus abdominis plane block onopioid consumption in patients undergoing laparoscopic sleeve gastrectomy after surgery.
POSTOPERATİVE T1:0 HOURS T2:4. HOURS T3:12.HOURS T4:24.HOURS
PATIENT SATISFACTION (Likert Scale) Not satisfied at all 1 Slightly satisfied 2 Moderately satisfied3 Satisfied4 Excellent5 SURGEON SATISFACTION (Likert Scale) Not satisfied at all 1 Slightly satisfied 2 Moderately satisfied3 Satisfied4 Excellent5
Time Frame: Postoperative 24.hours
Secondary outcomes will include patient- and surgeon-based Likert scale assessments.
Postoperative 24.hours
Postoperative Nause and Vomiting
Time Frame: Postoperative first 24.hours
Postoperative first 24.hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Melike Bostancı Erkmen, M.D., Sanliurfa Education and Research Hospital
  • Principal Investigator: Tolga Karaçay, M.D., Sanliurfa Education and Research Hospital
  • Principal Investigator: Servet Sürmeli, M.D., Sanliurfa Education and Research Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2026

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

May 1, 2027

Study Registration Dates

First Submitted

March 25, 2026

First Submitted That Met QC Criteria

April 20, 2026

First Posted (Actual)

April 23, 2026

Study Record Updates

Last Update Posted (Actual)

April 23, 2026

Last Update Submitted That Met QC Criteria

April 20, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No Ethics committee approval covers only aggregate data analysis; there is no permission to share individual participant data.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleeve Gastrectomy

Clinical Trials on Ultrasound-guided external oblique intercostal plane block

Subscribe